REFERENCES
- Bray, G. B. 1960. A simple efficient liquid scintillator for counting aqueous solutions in liquid scintillation counter. Analyt. Biochem. J. 279–285.
- Brömster, D., Carlberger, G., Lundh, G., Möller, J. & Rosén, A. 1968. The effect of some oral anticholinergics on gastric emptying, pH and osmolarity in man. Scand. J. Gastroent. 4, 185–192.
- Demling, L., Kinzlmeier, H. & Henning, N. 1952. Experimentelle Untersuchungen über die Wirkung inhibitorischer Pharmaka am menschlichen Magen. Gastroenterologia (Basel) 78, 269–282.
- Engstedt, L., Johansson, S. & Nyberg, A. 1967. Estimation of human erythrocyte life-span from bilirubin turnover. J. Lab. clin. Med. 70, 195–203.
- Guignard, J.-P., Herxheimer, A. & Greenwood, R. M. 1968. Effects of hyoscine butylbromide on gut motility. Clin. Pharmacol. Ther. 9, 745–748.
- Hydén, S. 1955. A turbidimetric method for the determination of higher polyethylene glycols in biological materials. Kungl. Lantbrukshögskolans Annaler 22, 139–145.
- Levine, R. M. 1959. The intestinal absorption of the quaternary derivatives of atropine and scopolamine. Arch. int. Pharmacodyn. 121, 146–149.
- Levine, R. M., Blair, M. R. & Clark, B. B. 1955. Factors influencing intestinal absorption of certain monoquaternary anticholinergic compounds with special reference to benzo-methamine. J. Pharmacol. exp. Ther. 114,78–86.
- Levine, R. M. & Clark, B. B. 1955. The biotransformation, excretion, and distribution of the anticholinergic quaternary ammonium compound benzomethamine (MC 3199) and its tertiary amine analog (MC 3137) and related compounds in animals. J. Pharmacol, exp. Ther. 114, 63–77.
- Levine, R. M. & Clark, B. B. 1957. The physiological disposition of oxyphenonium bromide (Antrenyl) and related compounds. J. Pharmacol. exp. Ther. 121, 63–70.
- Levine, R. M. & Pelikan, E. W. 1961. The influence of experimental procedures and dose on the intestinal absorption of an onium compound, benzomethamine. J. Pharmacol, exp. Ther. 131, 319–327.
- Nosslin, B. 1960. The direct diazo reaction of bile pigment in serum. Scand. J. clin. Lab. Invest. 12, Suppl. 49, 1–176.
- Pomeroy, A. R. & Rand, M. J. 1969. Anticholinergic affects and passage through the intestinal wall of N-butylhyoscine bromide. J. Pharm. Pharmacol. 21, 180–187.
- Reinecke, H. 1953. Röntgenologische Beobachtungen über die Beeinflussung der Magenund Gallenblasemotilität durch neue inhibitorisch wirkende Pharmaka. Klin. Wschr. 31, 465–469.
- Schmid, E., Bleichert, A., Kitzing, J. & Ritter, U. 1969. Hemmung der Dünndarmmotorik durch oral appliziertes Hyoscin-N-butylbromide. Arzneimittel-Forsch. 6, 998–999,
- Schmid, E., Bleichert, A., Überla, K., Ritter, U. & Fehlhaber, E. 1968. Die Testung oral applizierter Spasmolytika am Beispiel der Wirkung von Hyoscin-N-butylbromide auf die Magenmotilität. Arzneimittel-Forsch. 18, 1449–1453.
- Schöniger, W. 1955. Eine mikroanalytische Schnellbestimmung von Halogen in organischen Substanzen. Mikrochim. Acta 1, 123–129.
- Sielaff, H. J. 1953. Vergleichend experimentelle Untersuchungen über die Wirkung von Spasmolytika und Ganglienblockern (Atropin, Avacan, Pendiomid, Buscopan, Banthin) and die Motilität des Menschlichen Dünndarms. Ztschr. ges. exper. Med. 120, 599–612.
- Texter, E. C., Baylin, G. J., Legerton, C. W. & Ruffin, J. M. 1952. Effects of a new cholinergic blocking agent (SKF — 1937) on gastric motor and secretory activity. Amer. J. med. Sci. 224, 612–618,